Cost-consequence analysis of ofatumumab for the treatment of relapsing-remitting multiple sclerosis in Canada

• Main Authors: Virender Bhan (Author), Fraser Clift (Author), Moogeh Baharnoori (Author), Kimberly Thomas (Author), Barkha P Patel (Author), Francois Blanchette (Author), Nicholas Adlard (Author), Umakanth Vudumula (Author), Kapil Gudala (Author), Nikkita Dutta (Author), Daniel Grima (Author), Soukaina Mouallif (Author), Fatine Farhane (Author)
• Format: Book
• Published: Becaris Publishing Limited, 2023-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Aim: The costs and consequences of initial and delayed ofatumumab treatment were evaluated in relapsing-remitting multiple sclerosis with active disease in Canada. Materials & methods: A Markov cohort model was used (10-year horizon, annual cycle length, 1.5% discounting). Scenario analyses exam...